These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1346877

  • 1. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group.
    Ballard RA, Ballard PL, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I.
    Lancet; 1992 Feb 29; 339(8792):510-5. PubMed ID: 1346877
    [Abstract] [Full Text] [Related]

  • 2. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK.
    N Engl J Med; 1998 Feb 19; 338(8):493-8. PubMed ID: 9468465
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone.
    Ballard PL, Ballard RA, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I.
    Pediatr Res; 1992 Dec 19; 32(6):673-8. PubMed ID: 1287557
    [Abstract] [Full Text] [Related]

  • 5. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
    Crowther CA, Alfirevic Z, Han S, Haslam RR.
    Cochrane Database Syst Rev; 2013 Nov 21; 2013(11):CD000019. PubMed ID: 24265169
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
    Crowther CA, Alfirevic Z, Haslam RR.
    Cochrane Database Syst Rev; 2004 Nov 21; (2):CD000019. PubMed ID: 15106139
    [Abstract] [Full Text] [Related]

  • 7. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group.
    Am J Obstet Gynecol; 1998 Jan 21; 178(1 Pt 1):33-9. PubMed ID: 9465799
    [Abstract] [Full Text] [Related]

  • 8. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial.
    Gamsu HR, Mullinger BM, Donnai P, Dash CH.
    Br J Obstet Gynaecol; 1989 Apr 21; 96(4):401-10. PubMed ID: 2665800
    [Abstract] [Full Text] [Related]

  • 9. Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease.
    Lancet; 1995 Apr 08; 345(8954):877-82. PubMed ID: 7707809
    [Abstract] [Full Text] [Related]

  • 10. Prenatal thyrotropin-releasing hormone for preterm birth.
    Crowther CA, Alfirevic Z, Haslam RR.
    Cochrane Database Syst Rev; 2000 Apr 08; (2):CD000019. PubMed ID: 10796087
    [Abstract] [Full Text] [Related]

  • 11. Is there a role for antenatal TRH therapy for the prevention of neonatal lung disease?
    Gross I, Moya FR.
    Semin Perinatol; 2001 Dec 08; 25(6):406-16. PubMed ID: 11778911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group.
    Crowther CA, Hiller JE, Haslam RR, Robinson JS.
    Pediatrics; 1997 Mar 08; 99(3):311-7. PubMed ID: 9041281
    [Abstract] [Full Text] [Related]

  • 14. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH.
    Pediatrics; 1997 Oct 08; 100(4):E3. PubMed ID: 9310536
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.
    Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS, Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group.
    Lancet; 2006 Jun 10; 367(9526):1913-9. PubMed ID: 16765760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: stopping before the due date. Antenatal TRH Trial and the Thyroneth Trial Groups.
    Alfirevic Z, Boer K, Borcklehurst P, Buimer M, Elbourne D, Kok J, Tansey S.
    Br J Obstet Gynaecol; 1999 Sep 10; 106(9):898-906. PubMed ID: 10492099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
    Vermont Oxford Network Steroid Study Group.
    Pediatrics; 2001 Sep 10; 108(3):741-8. PubMed ID: 11533345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.